Emcure Pharmaceuticals Limited, a active public limited company, was established on 16 April 1981 in Pune City, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231PN1981PLC024251. Registered under ROC Roc Pune. it is listed. It has an authorized capital of ₹250.00 Cr and a paid-up capital of ₹189.56 Cr.
Formerly known as Emcure Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹3,635.91 Cr and a net worth of ₹1,935.10 Cr. Employing 6,877 professional, Its leadership includes Shailesh Kripalu Ayyangar (Director), Vijay Keshav Gokhale (Director), Berjis Minoo Desai (Director). Past directors included Amit Dixit, Mathew Cyriac, Jose Valentim Sartarelli. It holds ₹1,731.89 Cr open charges and ₹7,024.86 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. P-1 & P-2, It-Bt Park,, Phase-Ii, M.I.D.C., Pune City, Maharashtra, 411057.
L24231PN1981PLC024251
024251
16 April 1981
₹250.00 Cr
₹189.56 Cr
Roc Pune
Listed
Active
Explore comprehensive insights into Emcure Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Kripalu Ayyangar | Director | 16 Apr 2021 | Current |
| Vijay Keshav Gokhale | Director | 16 Apr 2021 | Current |
| Berjis Minoo Desai | Director | 03 Apr 1997 | Current |
| Satish Ramanlal Mehta | Ceo | 09 Nov 2020 | Current |
| Samit Satish Mehta | Whole-Time Director | 28 Jul 2022 | Current |
| Sunil Rajanikant Mehta | Whole-Time Director | 05 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 24 Feb 2011 | Past |
| Pramod Abcsdd | Alternate Director | 01 Jun 2009 | Past |
| Pramod Abcsdd | Director | 28 Feb 2013 | Past |
| Pramod Abcsdd | Director | 20 Oct 2014 | Past |
| Pramod Abcsdd | Company Secretary | 01 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Emcure Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 12.48% increase. The company also saw a slight improvement in profitability, with a 0.48% increase in profit. The company's net worth moved up by a moderate rise of 5.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Emcure Pharmaceuticals had a promoter holding of 54.42% and a public holding of 45.57%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹17,318,947,000.00
₹70,248,574,054.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2025 | Others | ₹100.00 Cr | Open |
| 12 Jun 2025 | Others | ₹250.00 Cr | Open |
| 15 May 2024 | Others | ₹100.00 Cr | Open |
| 04 May 2023 | Others | ₹175.00 Cr | Open |
| 25 Mar 2022 | Others | ₹275.00 Cr | Open |
Explore comprehensive loan charge details -
Emcure Pharmaceuticals has a workforce of 6877 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Emcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emcure Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101168650 was registered on 19 Sep 2025. was recorded as a recent event.
Emcure Pharmaceuticals Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 250.00 Cr with Charge ID 101117779 was registered on 12 Jun 2025. was recorded as a recent event.
Progress on Emcure Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
The activity A charge registered on 19 Nov 2020 via Charge ID 100393737 with Hdfc Bank Limited was fully satisfied on 27 Mar 2025. was completed.
A charge registered on 12 Nov 2020 via Charge ID 100392220 with Hdfc Bank Limited was fully satisfied on 27 Mar 2025. was recorded as a recent event.
The CIN of Emcure Pharmaceuticals Limited is L24231PN1981PLC024251.
Emcure Pharmaceuticals Limited is headquartered at Plot No. P-1 & P-2, It-Bt Park,, Phase-Ii, M.I.D.C., Pune City, Maharashtra, 411057.
Emcure Pharmaceuticals Limited was incorporated on 16 April 1981.
The current directors of Emcure Pharmaceuticals Limited are
The primary industry of Emcure Pharmaceuticals Limited is Manufacturing.
Emcure Pharmaceuticals Limited is listed.
The authorized capital of Emcure Pharmaceuticals Limited is ₹250.00 Cr, and the paid-up capital is ₹189.56 Cr.
The compliance status of Emcure Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX